Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.
about
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsA Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B VirusesI222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) virusesNeuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) VirusesIn vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.Impaired wound healing predisposes obese mice to severe influenza virus infection.Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.Animal Models for Influenza Virus Pathogenesis and Transmission.Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrateTreatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse ModelAntiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.Antigen-activated dendritic cells ameliorate influenza A infectionsOseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lungThe neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome.Influenza pharmacotherapy: present situation, strategies and hopes.Animal models in virus research: their utility and limitations.C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.
P2860
Q27314689-F41B79A7-D8FF-4734-8317-118EB4F6B34CQ27683640-354F4AD4-6BF3-4824-B827-3537F7FDFCF1Q28533778-EE66965C-EA70-4DDB-BDC6-0E2063DBBE36Q30372421-9D6193A4-427C-4179-9E22-F0C0ADD93D99Q30387420-75E5BB98-7C23-429B-8D9C-7BE9A7B60518Q30396885-E5666EAA-2322-4F5F-9BF7-7938598A2203Q30410362-BC82FD88-AA70-40BE-A27D-04CFA36430D2Q30427798-9B475292-77D2-4C4F-873E-1CF440EAB08FQ34714853-9524A9E7-61E3-40AA-8300-0FD0F51CF32FQ34971083-BAAB15FB-78C7-4781-AF4D-4FE8B702CAE8Q36301052-1CF61B2F-21B1-4A66-8EEA-C44FD36C3506Q36606607-C791922F-5D0A-4709-80FD-0E5580AF940AQ36730084-FBDABA51-DB53-4C0F-ADFF-3044CC5F4FD7Q36775625-EF8B993B-2287-44C0-977B-B7BAA6D3EDF6Q36828169-8F23C6BA-7B47-47F7-9CF2-8DD972BF0B81Q36966984-315C6FA8-4D23-4578-A684-F0719DF31285Q37087961-69E35B93-2B17-4926-8229-2C280BA42357Q37696588-1B508A79-C58C-48AA-A097-41D5D5DD91E2Q37857854-08BA8CA9-8D1D-454C-9632-8F74E5CFF11EQ38043556-2F306A35-E3CB-4C3E-8B96-377F632FB29EQ40112217-7CC40D9E-57F0-4063-9D23-33F1112FE2B9Q45859986-E03A4566-43DB-401C-9112-902355A95535
P2860
Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Susceptibility of highly patho ...... in vitro and in a mouse model.
@ast
Susceptibility of highly patho ...... in vitro and in a mouse model.
@en
type
label
Susceptibility of highly patho ...... in vitro and in a mouse model.
@ast
Susceptibility of highly patho ...... in vitro and in a mouse model.
@en
prefLabel
Susceptibility of highly patho ...... in vitro and in a mouse model.
@ast
Susceptibility of highly patho ...... in vitro and in a mouse model.
@en
P2093
P2860
P356
P1476
Susceptibility of highly patho ...... in vitro and in a mouse model.
@en
P2093
Bounlom Douangngeun
Jennifer L McClaren
Natalia A Ilyushina
Tri S P Naipospos
P2860
P304
P356
10.1128/AAC.01667-08
P407
P577
2009-04-06T00:00:00Z